SCHEMBL19557286

SCHEMBL19557286

CC[Si](CC)(CC)c1cc2cccc(C)c2n1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TLR8 Q9NR97 2/20 0.36
▸ ALKBH5 Q6P6C2 1/20 0.35
▸ FTO Q9C0B1 1/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ CRHR1 P34998 2/20 0.32
▸ CASR P41180 1/20 0.32
▸ TLR7 Q9NYK1 1/20 0.32
▸ ESR1 P03372 1/20 0.31
▸ KDM4E B2RXH2 3/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ CYP2A6 P11509 2/20 0.31
▸ KLK7 P49862 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ ADRA2B P18089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12278913 0.76 — —
SCHEMBL22502897 0.74 ALKBH5 (0.38) MEN1NPC1HCRTR1RAB9AKMT2A
SCHEMBL30444626 0.74 KMT2A (0.46) MEN1KMT2AKDM4EALDH1A1ADRA2A
SCHEMBL29509065 0.73 ALKBH5 (0.42) KMT2ATLR8ALKBH5FTOCYP1A2
SCHEMBL17504843 0.73 ALKBH5 (0.42) KMT2ATLR8ALKBH5FTOCYP1A2
SCHEMBL1092872 0.72 ALKBH5 (0.42) MEN1NPC1HCRTR1RAB9AKMT2A
SCHEMBL19557287 0.70 KDM4E (0.36) MEN1KMT2ACYP1A2KDM4EALDH1A1
SCHEMBL15639395 0.70 ATM (0.38) MEN1NPC1RAB9AKMT2ACYP1A2
SCHEMBL19559062 0.70 ALKBH5 (0.35) MEN1NPC1HCRTR1RAB9AKMT2A
SCHEMBL3229629 0.70 TAAR1 (0.39) MEN1NPC1HCRTR1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380943-A1 METHOD FOR THE SILYLATION OF A C-H BOND WITH A SILYLATED DIAZENE SORBONNE UNIVERSITE (FR) 2024-06-12 — — EP disclosed
US-11753421-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-09-12 — — US disclosed
US-11753421-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-09-12 — — US disclosed
CN-111253424-B Silylation of aromatic heterocycles over earth-rich transition metal-free catalysts 加州理工学院 2023-06-20 — — CN disclosed
EP-3705482-B1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS CALIFORNIA INST OF TECHN (US) 2023-02-22 — — EP disclosed
WO-2023012494-A1 METHOD FOR THE SILYLATION OF A C-H BOND WITH A SILYLATED DIAZENE SORBONNE UNIVERSITE (FR) 2023-02-09 — — WO disclosed
US-20220185828-A1 Silylated Derivatives Of Aromatic Heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY 2022-06-16 — — US disclosed
US-11312733-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2022-04-26 — — US disclosed
CN-111253424-A Silylation of aromatic heterocycles by earth-rich transition metal-free catalysts 加州理工学院 2020-06-09 — — CN disclosed
CN-107108662-B9 Silylation of aromatic heterocycles by earth-rich transition metal-free catalysts 加州理工学院 2020-05-15 — — CN disclosed
CN-107108662-B Silylation of aromatic heterocycles by earth-rich transition metal-free catalysts 加州理工学院 2020-02-07 — — CN disclosed
US-20180057514-A1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS CALIFORNIA INSTITUTE OF TECHNOLOGY 2018-03-01 — — US disclosed
US-9809607-B2 Silylation of aromatic heterocycles by earth abundant transition-metal-free catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-11-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312733-B2 Silylated derivatives of aromatic heterocycles KCNH1, KCNH3, HNRNPH3 MEN1 3045/4885NPC1 1172/4885HCRTR1 4471/4885
US-20180057514-A1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS TEC, AURKA, TYR MEN1 806/4885NPC1 1990/4885HCRTR1 4821/4885
US-11753421-B2 Silylated derivatives of aromatic heterocycles KCNH1, KCNH3, HNRNPH3 MEN1 3045/4885NPC1 1172/4885HCRTR1 4471/4885
US-20220185828-A1 Silylated Derivatives Of Aromatic Heterocycles KCNH1, KCNH3, HNRNPH3 MEN1 3045/4885NPC1 1172/4885HCRTR1 4471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback